Jones Financial Companies
NERV icon

Jones Financial Companies’s Minerva Neurosciences NERV Stock Holding History

Jones Financial Companies’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57
Closed -$101 – 4330
2025
Q2 		$101 Buy
+57
New +$93 ﹤0.01% 3950

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jones Financial Companies's NERV Position: Q3 2025 in Review

Jones Financial Companies sold out of Minerva Neurosciences (NERV) in Q3 2025, closing a stake of 57 shares — an estimated $101 sold.

Jones Financial Companies first reported a position in NERV in Q2 2025 and held it in 1 quarter. The position peaked at $101 in Q2 2025. 24 funds tracked by Wall St. Rank hold NERV as of Q3 2025.

  • Jones Financial Companies reported no remaining Minerva Neurosciences position as of Q3 2025 after selling out during the quarter.
  • Jones Financial Companies sold 57 Minerva Neurosciences shares in Q3 2025, an estimated $101.
  • Jones Financial Companies first reported a position in Minerva Neurosciences in Q2 2025 and held it in 1 quarter.
  • Jones Financial Companies's Minerva Neurosciences position peaked at $101 in Q2 2025.
  • 24 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2025.

Based on Jones Financial Companies's 13F filing for Q3 2025, filed 4 Nov 2025.